52630

🔬 CPT 52630 — Transurethral Resection; Residual or Regrowth of Obstructive Prostate Tissue, Complete (Secondary TURP)

Quick Reference

wRVU: 8.35 (verify CMS Addendum B 2026) | Global Period: 090 (90 days) | Assistant Payable: ✅ Yes | Bilateral Indicator: 0

---

📋 Clinical Description

CPT 52630 describes a complete transurethral electrosurgical resection of residual or regrown obstructive prostate tissue, performed as a secondary (repeat) procedure in a patient who has previously undergone a TURP or similar prostate resection. The procedure uses a resectoscope introduced transurethrally; the surgeon resects tissue chips from the previously resected prostatic bed using a wire loop electrode, followed by chip evacuation, hemostasis, and postoperative bladder irrigation. This code differs from its sibling 52601 (initial TURP) in one critical dimension: 52630 is used exclusively when the patient has a documented history of prior prostate resection — the distinction is prior surgical history, not the technique performed, which is otherwise identical.

Benign prostatic hyperplasia (BPH) with LUTS is the most common underlying condition driving 52630. After an initial TURP (52601), a subset of patients develop either residual obstructive tissue (incompletely resected at the original procedure) or true adenoma regrowth over time; both are captured under this single code regardless of the clinical determination of “residual” versus “regrowth,” as the two are often clinically indistinguishable intraoperatively.^{1, 2} Note that CPT 52620 (formerly used for residual tissue at 90 days postop) was deleted; 52630 is now the single code for all secondary TURP procedures regardless of time elapsed.³

This procedure may be performed in the following clinical contexts:

• Repeat TURP for BPH regrowth — most common indication; patient had initial TURP years prior and re-presents with recurrent LUTS/obstructive voiding; no acute global period of the original procedure remains
• Return for residual obstructive tissue within the 90-day global window — procedure performed before expiration of the original TURP’s 90-day global; modifier -78 required to indicate unplanned return to OR for related procedure during postoperative period
• Planned staged second-look procedure — provider planned a two-stage resection at the time of the original operation; modifier -58 applies to signal the procedure is staged or related and planned
• Post-BPH-medication failure with prior TURP history — patient who underwent prior TURP, achieved partial relief, was managed medically, but now presents with progressive LUTS or urinary retention requiring surgical re-intervention
• Secondary obstruction following other prostate procedures — e.g., patient with prior laser vaporization (52648) who develops recurrent obstruction; note: some coding sources distinguish prior laser-only procedures from prior resections when selecting 52630 — document the prior procedure type carefully and query the provider if unclear²

---

🔬 Anatomical & Procedural Considerations

Procedural Phase	Steps / Mechanism	Key Coding & Clinical Notes
Patient Positioning & Scope Insertion	Patient in dorsal lithotomy; resectoscope passed transurethrally under direct visualization	Cystourethroscopy is bundled — do not separately bill 52000
Assessment of Prior Resection Bed	Surgeon inspects the prostatic fossa and vesical neck for residual adenoma, scar tissue, or regrowth; urethral calibration performed if indicated	Operative note must document prior surgical history and findings distinguishing this from an initial TURP; this documentation differentiates 52630 from 52601 on audit
Electrosurgical Resection	Wire loop electrode resects tissue in systematic passes; chips fall into bladder; same technique as 52601 but performed in previously altered anatomy	Bleeding risk is typically higher in a re-operative field; hemostasis documentation supports medical necessity
Chip Evacuation & Hemostasis	Ellik evacuator or irrigation used to remove tissue chips; coagulation of bleeding vessels; postoperative catheter placement	Control of postoperative bleeding is included — do not bill separately
Vasectomy / Meatotomy / Internal Urethrotomy	Performed only when clinically indicated; bundled into 52630 per descriptor	These services are always bundled whether or not they are actually performed — they cannot be separately billed

Clinical Pearl

The single most important documentation element for 52630 is clear reference to prior prostate resection in the operative report. Without explicit documentation of prior TURP (or equivalent prostate surgery) history, the claim is susceptible to downcoding to 52601. Operative notes should state: “Patient presents with history of prior TURP [date] with recurrent obstructive symptoms; intraoperative findings consistent with regrowth/residual tissue.” The clinical distinction between “regrowth” and “residual” is not required for code selection — 52630 captures both.^{1, 2}

---

✅ Procedure Includes

• Pre-procedure cystourethroscopy and evaluation of the prostatic bed
• General or spinal anesthesia coordination (anesthesia billed separately by anesthesiologist under 00910 or 00914)
• Transurethral introduction and manipulation of resectoscope
• Electrosurgical wire-loop resection of obstructive prostate tissue, complete
• Irrigation and evacuation of tissue chips
• Control of postoperative bleeding (fulguration, coagulation)
• Urethral calibration and/or dilation, when performed
• Meatotomy, when performed
• Internal urethrotomy, when performed
• Vasectomy, when performed
• Indwelling catheter placement for postoperative drainage
• Routine postoperative care within the 90-day global period

---

❌ Excludes / Do Not Report Together

Code	Description	Relationship to 52630
52601	Transurethral electrosurgical resection of prostate, complete — initial	Mutually exclusive by patient history: 52601 = first TURP; 52630 = any subsequent TURP. Report one or the other — never both for the same session
52648	Laser vaporization of prostate, complete	Alternative technology code; do not report with 52630 for the same anatomic site same session — the procedure is either electrosurgical resection OR laser vaporization, not both
52000	Cystourethroscopy	Bundled by NCCI into 52630; cystoscopy is an integral component and cannot be separately billed
52500	Transurethral incision of prostate (TUIP)	Bundled into 52630 per NCCI; incision is included in or subsumed by resection
52450	Transurethral incision of prostate	Bundled per NCCI — incision components are integral to complete resection
E/M codes (992xx)	Office visit, any level	Separately reportable only when modifier -25 is appended to the E/M code documenting a significant, separately identifiable service beyond the pre-procedure assessment

Bundling Alert — Global Period is 090, Not 000

52630 carries a 90-day global period, identical to the initial TURP (52601). This means all routine follow-up visits, catheter checks, and procedure-related E/M services for 90 days post-procedure are bundled into the procedure payment. The most common audit finding is separate billing of office visits for foley removal, post-void residual checks, or urinary symptom follow-up within the 90-day window. If the patient presents during the global period for a condition unrelated to the prostate procedure, append modifier -24 to the E/M code and document the unrelated nature explicitly. Do not confuse the global period of 52630 with the 000-day global of cystoscopy codes — they are entirely different code families.

---

🌳 Code Tree — Surgery: Urinary System / Endoscopy: Vesical Neck and Prostate

52400-52700  Surgery: Urinary System — Endoscopy: Transurethral
│
├── 52400-52402  Transurethral Incision
│   ├── 52400  Cystourethroscopy with incision, fulguration, or resection of congenital posterior urethral valves
│   └── 52402  Cystourethroscopy with transurethral resection or incision of ejaculatory ducts
│
├── 52450-52640  Vesical Neck and Prostate Procedures
│   ├── 52450  Transurethral incision of prostate  (Global: 090)
│   ├── 52500  Transurethral resection of bladder neck  (Global: 090)
│   ├── 52601  Transurethral electrosurgical resection of prostate, complete — initial  (Global: 090)
│   ├── ▶▶ 52630 ◀◀  Transurethral resection; residual or regrowth of obstructive prostate tissue, complete  ← YOU ARE HERE  (Global: 090)
│   ├── 52640  Transurethral resection; of postoperative bladder neck contracture  (Global: 090)
│   ├── 52647  Laser coagulation of prostate, complete  (Global: 090)
│   ├── 52648  Laser vaporization of prostate, complete  (Global: 090)
│   ├── 52649  Laser enucleation of prostate with morcellation, complete  (Global: 090)
│   └── 52597  Transurethral robotic-assisted waterjet resection of prostate, complete  (Global: 090) *(New 2026)*
│
└── 52700  Transurethral drainage of prostatic abscess

---

💰 RVU & Reimbursement Profile

Component	Value
Work RVU (wRVU)	8.35 (verify against CMS MPFS Addendum B 2026; RUC recommendation accepted per CMS-1832-F; 2.5% efficiency adjustment applied to all non-time-based services effective 2026)4
Global Period	090 (90 days)
Bilateral Indicator	0 — Not applicable; prostate is a single midline structure; bilateral billing rules do not apply
Assistant Surgeon	✅ Payable
Co-Surgeon	❌ Not applicable
Team Surgery	❌ Not applicable
PC/TC Split	❌ No — Procedure Code Only (Indicator 0)
Modifier -51 Exempt	No
Anesthesia	General or spinal anesthesia; separately billable by anesthesiologist under CPT 00910 (cystoscopy anesthesia) or 00914 (TURP anesthesia); not included in 52630 payment

Bilateral Billing Rules

52630 has a bilateral indicator of 0, meaning standard bilateral billing rules do not apply — the prostate is a single midline organ and bilateral procedure concepts are not relevant. Do not append modifier -50, -RT, or -LT to this code. If a second distinct urologic procedure is performed at the same session (e.g., cystoscopy with stone removal — where separately payable), that code is billed independently with modifier -51 on the lower-valued code; 52630 is sequenced first as the primary procedure.

---

🏷️ Modifier Reference

Modifier	Name	When to Apply
-78	Unplanned Return to OR — Related Procedure	Applied to 52630 when performed within the 90-day global period of the original TURP (52601) for residual or regrowth tissue — unplanned return; payment is reduced (approximately 70% of the procedure fee); append to 52630, not the E/M
-58	Staged or Related Procedure	Applied to 52630 when the repeat resection was planned at the time of the original procedure (e.g., documented two-stage TURP plan); initiates a new 90-day global period
-25	Significant, Separately Identifiable E/M	Applied to the E/M code — not 52630 — when an office visit is performed on the same date as the procedure and the documentation supports a separate, medically necessary evaluation beyond the routine pre-procedure assessment
-24	Unrelated E/M During Postoperative Period	Applied to the E/M code when a patient returns within the 90-day global window for a condition unrelated to the prostate procedure; document the unrelated condition explicitly in the record
-51	Multiple Procedures	When 52630 is performed alongside other separately reportable surgical procedures in the same session; apply -51 to the lower-valued procedure
-59	Distinct Procedural Service	When a payer inappropriately bundles a separately reportable distinct service with 52630; documents distinct anatomic site or independent service
-52	Reduced Services	Procedure partially completed — operative note must document reason (e.g., patient hemodynamic instability requiring termination before complete resection)
-53	Discontinued Procedure	Procedure terminated after start due to patient safety concern — document thoroughly; payment at reduced rate
-79	Unrelated Procedure During Postoperative Period	Unrelated surgical procedure performed during the 90-day global window; document the unrelated indication

---

🩺 Common ICD-10-CM Pairings

BPH and Nodular Prostate — Primary Obstruction Diagnoses

ICD-10 Code	Description	HCC?	Clinical Notes
N40.1	Benign prostatic hyperplasia with lower urinary tract symptoms	❌ No	Most common primary diagnosis; LUTS must be documented (frequency, nocturia, weak stream, retention, hesitancy); if LUTS are not documented, assign N40.0
N40.0	Benign prostatic hyperplasia without lower urinary tract symptoms	❌ No	Use when BPH is documented but provider does not document accompanying LUTS; less common in the surgical coding context
N40.3	Nodular prostate with lower urinary tract symptoms	❌ No	Use when provider specifically documents “nodular prostate” rather than BPH/adenoma; functionally similar to N40.1 for coding purposes but follow documentation
N40.2	Nodular prostate without lower urinary tract symptoms	❌ No	Nodular prostate, no LUTS documented

Urinary Retention and Obstructive Uropathy

ICD-10 Code	Description	HCC?	Clinical Notes
R33.8	Other retention of urine	❌ No	Assign as additional diagnosis when acute or chronic urinary retention is documented as a presenting symptom or comorbidity; do not assign R33.9 (unspecified) if a specific cause is documented — link to the BPH code as etiology
N13.8	Other obstructive and reflux uropathy	❌ No	Use when obstructive uropathy is documented as a complication of BPH/prostatic obstruction; supports severity and medical necessity narrative

Personal and Family History / Status Codes

ICD-10 Code	Description	HCC?	Clinical Notes
Z85.46	Personal history of malignant neoplasm of prostate	✅ HCC 12	Assign as additional diagnosis when patient has documented history of treated prostate cancer and the current procedure is for BPH/obstruction, not recurrence; confirm with provider that the obstruction is benign in etiology, not recurrent malignancy — a critical query trigger
Z87.39	Personal history of other endocrine, nutritional and metabolic diseases	❌ No	May be relevant in patients with history of metabolic conditions affecting prostate pathology; typically not primary

Underlying Etiology / Complication Codes

ICD-10 Code	Description	HCC?	Clinical Notes
N99.12	Postprocedural urethral stricture, male, membranous urethra	❌ No	When postoperative stricture complicates the prior TURP and contributes to the obstruction requiring 52630; report as additional diagnosis
N32.0	Bladder-neck obstruction	❌ No	Report as additional diagnosis if provider separately documents bladder neck contribution to obstruction beyond the prostatic component

Coding Specificity Reminder

The N40 family requires specificity on LUTS documentation — the axis is “with LUTS” versus “without LUTS,” and LUTS must be explicitly stated by the provider (frequency, urgency, nocturia, weak stream, incomplete emptying, hesitancy, or retention qualify). Do not infer LUTS from symptom codes alone without provider linkage. When the patient also has a history of prostate cancer, a query is mandatory before assigning N40.x — the provider must confirm the obstruction is benign and not related to cancer recurrence or radiation effect, as a completely different code family would apply (e.g., C61 or Z85.46 as primary vs. additional).

---

🏥 MS-DRG Considerations (Inpatient)

Inpatient Coding Reminder

CPT 52630 is performed primarily in the outpatient or ASC setting. However, inpatient admission may occur in patients with significant comorbidities, urinary retention requiring extended management, or postoperative complications. When this procedure drives or occurs during an inpatient admission, ICD-10-PCS coding is required for facility reimbursement. The procedure maps to MDC 11 — Diseases and Disorders of the Kidney and Urinary Tract and the following DRG family based on CC/MCC tier:

DRG	Title	CC/MCC Status	Typical GMLOS
672	Urethral Procedures with MCC	With MCC	~4.6 days
673	Urethral Procedures with CC	With CC	~2.5 days
674	Urethral Procedures without CC/MCC	Without CC/MCC	~1.5 days

Note: DRG assignment is driven by the ICD-10-PCS procedure code, not the CPT code. Confirm PCS root operation selection (Excision vs. Resection) per procedural documentation — see PCS section below.

---

🔧 ICD-10-PCS Equivalents (Inpatient Facility Coding)

Note

Inpatient PCS coding for TURP procedures is encountered when a patient is admitted for surgical management of BPH or prostatic obstruction, most often in patients with urinary retention, significant comorbidities, or postoperative complications. PCS root operation selection for TURP depends on the extent of tissue removal: Excision (B) is used when a portion of the prostate adenoma is removed (which is the standard for TURP — the entire adenoma zone is not always removed), while Resection (T) would apply only if the entire prostate is removed — Excision is the correct root operation for TURP in nearly all clinical scenarios. The approach is Via Natural or Artificial Opening Endoscopic (Character 8) for transurethral procedures.

PCS Code	Full Description	Notes
0VB08ZZ	Excision of Prostate, Via Natural or Artificial Opening Endoscopic, No Device, No Qualifier	Standard PCS code for inpatient TURP (52630); Excision = taking out a portion of a body part
0VT08ZZ	Resection of Prostate, Via Natural or Artificial Opening Endoscopic, No Device, No Qualifier	Use only if entire prostate is removed transurethrally — rare; does not apply to standard TURP

PCS Character Analysis — 0VB08ZZ

Position	Character	Value	Definition
1	Section	0	Medical and Surgical
2	Body System	V	Male Reproductive System
3	Root Operation	B	Excision (cutting out or off, without replacement, a portion of a body part)
4	Body Part	0	Prostate
5	Approach	8	Via Natural or Artificial Opening Endoscopic
6	Device	Z	No Device
7	Qualifier	Z	No Qualifier

PCS Root Operation: Excision (B) vs. Resection (T)

• Use Excision (B) when the procedure removes a portion of the prostate — this is the correct root operation for all TURP procedures including 52630, as the entire prostate is never removed transurethrally
• Use Resection (T) only when the entire body part is removed — not applicable to standard TURP; would apply to radical prostatectomy via endoscopic approach if technically performed as complete removal
• The qualifier X (Diagnostic) would convert 0VB08ZZ to 0VB08ZX for prostate biopsy only — never append diagnostic qualifier to a therapeutic resection

---

📝 Coding Examples

---

Example 1 — ASC: Repeat TURP for BPH Regrowth, No Active Global Period

Clinical Scenario: A 74-year-old male with a documented history of TURP three years prior now presents with recurrence of urinary frequency, nocturia, and weak urinary stream. Urodynamics confirm BOO. Cystoscopy reveals regrowth of adenoma tissue in the prostatic fossa. The urologist performs a complete transurethral resection using a wire-loop resectoscope, resecting regrowth tissue, irrigating, evacuating chips, and achieving hemostasis. Operative report states: “History of prior TURP [date]; current procedure for regrowth of obstructive tissue, complete resection performed.” No E/M on the same date.

Field	Code	Rationale
CPT	52630	Repeat/secondary TURP — prior TURP documented; complete resection of regrowth tissue; no modifier needed as prior global period has long expired
PDx	N40.1	BPH with LUTS — provider documents frequency, nocturia, weak stream; LUTS explicitly stated
SDx	R33.8	Urinary retention documented as associated finding on urodynamics

Note

No modifier is required on 52630 when no active global period from a prior prostate procedure exists. The documentation of prior TURP history is the sole distinguishing factor from 52601 — ensure operative report language clearly supports the repeat-procedure nature of the service.

---

Example 2 — Hospital Outpatient: Repeat Resection Within 90-Day Global of Initial TURP

Clinical Scenario: A 68-year-old male undergoes initial TURP (52601) 45 days ago. He returns with persistent obstructive voiding; cystoscopy reveals significant residual adenoma at the 6 and 12 o’clock positions. The urologist takes the patient back to the OR for transurethral resection of the residual tissue; complete hemostasis achieved. This was not planned at the time of the original procedure. Operative note: “Unplanned return to OR for residual obstructive tissue following TURP 45 days prior.”

Field	Code	Rationale
CPT 1	52630-78	Secondary TURP within 90-day global of initial TURP; modifier -78 = unplanned return to OR for related procedure during postoperative period; payment reduced to approximately 70% of standard rate
PDx	N40.1	BPH with LUTS — original indication; residual obstruction is a continuation of same pathology
SDx	R33.8	Persistent urinary retention documented

Warning

Modifier -78 must be appended to 52630 (not the original 52601 claim) to indicate unplanned return to OR within the global period. A new 90-day global period does not start when -78 is used; the original global clock continues from the date of the initial TURP. If the second procedure had been planned and documented at the time of the original surgery, modifier -58 would apply instead, which does initiate a new 90-day global period.

---

Example 3 — Inpatient: Repeat TURP with Postoperative Urinary Retention and Comorbidity

Clinical Scenario: A 79-year-old male with CKD Stage 3a and BPH with LUTS presents with acute urinary retention requiring Foley placement. He has a history of TURP six years prior. After urologic evaluation, he is admitted for secondary TURP given his CKD and anesthetic risk requiring close monitoring. The procedure is performed via resectoscope; complete resection of regrowth tissue achieved with hemostasis. Postoperatively the patient requires IV fluid management given CKD. Admission supported medically.

Field	Code	Rationale
CPT	52630	Secondary TURP — prior TURP documented; complete resection
PCS	0VB08ZZ	Excision of Prostate, Via Natural or Artificial Opening Endoscopic — inpatient facility code
PDx	N40.1	BPH with LUTS — principal reason for admission and surgery
SDx	R33.8	Acute urinary retention — documented as acute presentation triggering admission
SDx	N18.31	CKD Stage 3a — documented comorbidity affecting postoperative management; status as CC elevates DRG grouping

Global period reminder:

The 90-day global period for this inpatient 52630 begins on the date of surgery. All related outpatient follow-up, foley removal visits, and symptom checks within the 90-day window are bundled. Any visits for CKD management or unrelated conditions within that window require modifier -24 on the E/M code with documentation of the unrelated nature. On the inpatient side, the PCS code 0VB08ZZ triggers DRG 672/673/674; the presence of CKD Stage 3a as a confirmed CC moves grouping from DRG 674 to DRG 673 — document and code all CCs/MCCs present to ensure accurate DRG assignment.

---

⚠️ Common Coding Pitfalls

• Billing 52601 instead of 52630 for a repeat TURP: The single most common TURP coding error. If the patient has any prior TURP or equivalent prostate resection, 52630 is required — 52601 is for the initial, never-previously-resected prostate. Submitting 52601 for a patient with documented prior TURP is an inaccurate claim. Review the surgical history at the time of coding; if unclear, query the provider before submitting.
• Missing modifier -78 when within global period: When a patient returns for 52630 within the 90-day global of an initial TURP, modifier -78 (unplanned return to OR, related procedure) is required. Omitting -78 will result in claim denial, as the payer’s system will see a procedure billed during an active global period without a modifier overriding it. The distinction between -78 (unplanned, no new global) and -58 (planned, new global started) must be supported by operative documentation.
• Separately billing bundled components: CPT 52000 (cystoscopy), 52450 (TUIP), and 52500 (bladder neck resection) are all bundled into 52630 per NCCI. Reporting 52000 with 52630 for the same session will result in denial of 52000. The procedure descriptor explicitly states that cystourethroscopy is included; operative report language confirming these as integral steps does not justify separate billing.
• Misapplying the 90-day global to the E/M: Billing routine office visits within the 90-day global window without a modifier is a top audit finding. Post-TURP visits for foley management, catheter removal, urinary symptom follow-up, and post-void residual checks are all bundled into the 52630 payment. Separate billing of these visits without modifier -24 (for unrelated services) creates overpayment liability and recoupment risk, particularly under Medicare.
• Using 52630 after laser vaporization (not prior TURP): Some coding sources note that 52630 is most accurately applied when the prior prostate procedure was also a resection (TURP). When the prior procedure was laser vaporization (52648) and the current procedure is electrosurgical resection, documentation clarity is essential — the provider should specify the prior procedure type, and the coder should query if the operative report does not explicitly address this distinction. Defaulting to 52630 after any prior prostate procedure type without documentation review is a potential audit vulnerability.
• Neglecting the personal history of prostate cancer query: When Z85.46 appears in the record alongside BPH codes, a provider query is mandatory before coding. The provider must confirm the obstruction is benign in etiology and not related to prostate cancer recurrence, radiation fibrosis, or biochemical recurrence. Assigning N40.1 without this confirmation when a history of malignancy exists is a clinical documentation integrity failure.

---

📎 Sources

¹ AMA CPT 2026 Professional Edition — Surgery: Urinary System, Endoscopy: Vesical Neck and Prostate, Code 52630 | ² AAPC Urology Coding Alert — “52601 and 52630: Avoid TURP Denials By Learning the Nuances of These 2 Codes” (2011, principles current) | ³ Medical Bill Gurus — “Transurethral Resection of Prostate Billing Guide: CPT 52620 Deletion and 52630 Descriptor Revision” (2024) | ⁴ CMS CY 2026 Medicare Physician Fee Schedule Final Rule (CMS-1832-F), Federal Register Vol. 90, November 5, 2025 — Transurethral Robotic-Assisted Resection of Prostate section (p. 250); RUC-recommended wRVU accepted for CPT 52630; 2.5% efficiency adjustment finalized for all non-time-based services | ⁵ AUA 2026 MPFS Final Rule Summary — CPT codes 52500, 52601, 52630, 52648, 52649, and 52597 resurvey; published November 2025 | ⁶ ICD-10-CM Official Guidelines for Coding and Reporting FY2026 | ⁷ ICD-10-PCS Official Guidelines for Coding and Reporting FY2026 — Section B3.4 (Biopsy vs. Non-Biopsy), Root Operation Definitions (Excision vs. Resection) | ⁸ CMS NCCI Policy Manual for Medicare Services, Chapter 7 (Radiology), Chapter 11 (Urinary System), 2025-2026 | ⁹ CMS Medicare NCCI PTP Edits v320r0, effective January 1, 2026 — 52000/52630 bundle confirmed